phenazopyridine has been researched along with lidocaine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Caron, G; Ermondi, G | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Bailey, MK; Baker, JD; Conroy, JM; Dorman, BH; Martin, WJ | 1 |
| Aizawa, N; Wyndaele, JJ | 1 |
| Jacobs, KM; Raker, CA; Siddique, M; Stewart, LE; Sung, VW | 1 |
1 trial(s) available for phenazopyridine and lidocaine
| Article | Year |
|---|---|
Oral phenazopyridine vs intravesical lidocaine for bladder onabotulinumtoxinA analgesia: a randomized controlled trial.
Topics: Adult; Analgesia; Botulinum Toxins, Type A; Female; Humans; Lidocaine; Pain; Phenazopyridine; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive | 2022 |
8 other study(ies) available for phenazopyridine and lidocaine
| Article | Year |
|---|---|
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Acquired methemoglobinemia from multiple oxidants.
Topics: Administration, Topical; Adult; Analgesia, Epidural; Blood Gas Analysis; Bupivacaine; Cytochrome-B(5) Reductase; Female; Humans; Lidocaine; Methemoglobinemia; Oximetry; Oxygen Inhalation Therapy; Pain; Phenazopyridine; Urination Disorders; Uterine Neoplasms | 1993 |
Effects of phenazopyridine on rat bladder primary afferent activity, and comparison with lidocaine and acetaminophen.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anesthetics, Local; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Female; Lidocaine; Mechanotransduction, Cellular; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neurons, Afferent; Phenazopyridine; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urodynamics | 2010 |